This bill aims to repeal the prescription drug affordability board, which is currently established under New Hampshire law. Specifically, it amends RSA 94:1-a, I(b) by deleting the position of the executive director of the prescription drug affordability board from the Department of Health and Human Services. Additionally, it repeals RSA 6:12, I(b)(384), which pertains to the administration fund for the board, and RSA 126-BB, which outlines the board's functions and responsibilities.

The effective date for this repeal is set for July 1, 2025. The bill is noted to have no fiscal impact, as the board has already been effectively repealed by a previous bill (HB 2) from the 2025 session. Consequently, there are no expected changes in revenue or expenditures associated with this repeal.

Statutes affected:
Introduced: 126-BB:1, 126-BB:2
As Amended by the House: 94:1-a